Preclinical activity of a novel multi-axis inhibitor in aggressive and indolent B-cell malignancies. Smith AL, Pal D, Martinez-Rico R, Eiken AP, et al. Leuk Lymphoma 2023;64:2333-2337.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Smith AL, Pal D, Martinez-Rico R, Eiken AP, et al. Preclinical activity of a novel multi-axis inhibitor in aggressive and indolent B-cell malignancies. Leuk Lymphoma 2023;64:2333-2337.
PMID: 37706519